FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [ · ], between Jaguar Animal Health, Inc., a Delaware corporation (the “Company”), and [ · ](“Indemnitee”).
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 5th day of February, 2014, by and among Jaguar Animal Health, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
EMPLOYEE LEASING AND OVERHEAD ALLOCATION AGREEMENTEmployee Leasing and Overhead Allocation Agreement • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • California
This EMPLOYEE LEASING AND OVERHEAD ALLOCATION AGREEMENT (the “Agreement”), dated July 1, 2013, is made and entered into by and between Napo Pharmaceuticals, Inc., a Delaware corporation (“Napo”), and Jaguar Animal Health, Inc., a Delaware corporation (“JAG”), with reference to the following facts:
FORM OF CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • California
THIS CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is dated for references purposes as of June 2, 2014 (the “Effective Date”), by and between Jaguar, Inc., a Delaware corporation (the “Company”) and the investor whose name and signature are set forth on the signature page to this Agreement (the “Investor”).
AMENDED AND RESTATED LICENSE AGREEMENT by and between NAPO PHARMACEUTICALS, INC. and JAGUAR ANIMAL HEALTH, INC. originally dated as of January 27, 2014 and amended and restated as of August 6, 2014License Agreement • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • California
This Amended and Restated License Agreement (this “Agreement”) is made originally as of January 27, 2014 (the “Effective Date”) and amended and restated as of August 6, 2014 (the “Restatement Date”), by and between Napo Pharmaceuticals, Inc., a Delaware corporation, having offices located at 185 Berry Street, Suite 1300, San Francisco, California 94107 (“Napo”), and Jaguar Animal Health, Inc., a Delaware corporation, having offices located at 185 Berry Street, Suite 1300, San Francisco, California 94107 (“JAH”). Napo and JAH are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” All capitalized terms used herein are defined either in the Section 1 below or within the context of the section where the term is first used in this Agreement. This Agreement as amended and restated as of the Restatement Date amends and restates (and replaces and supersedes) in its entirety this Agreement as originally executed, to the extent of any conflict, all of the f
JAGUAR ANIMAL HEALTH, INC. COMMON STOCK WARRANTJaguar Animal Health, Inc. • August 11th, 2014 • Pharmaceutical preparations • Delaware
Holder is an “accredited investor” as that term is defined in Regulation D promulgated by the Securities and Exchange Commission. The term “Accredited Investor” under Regulation D refers to:
ContractPurchase Agreement • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • Delaware
THIS CONVERTIBLE PROMISSORY NOTE AND ANY SECURITIES INTO WHICH THIS CONVERTIBLE PROMISSORY NOTE IS CONVERTIBLE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR QUALIFICATION OR AN EXEMPTION THEREFROM UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
ASSIGNMENT OF SUBLEASE AND CONSENT OF LANDLORDOffice Lease • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • California
This Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between PWREF/MCC-CHINA BASIN L.L.C., a Delaware limited liability company (“Landlord”), and BCCI CONSTRUCTION COMPANY, a California corporation (“Tenant”).
